SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT

This adverse event was reported 1245 times

These drugs are most commonly taken by patients reporting SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT:

# Drug Count
0 BEVACIZUMAB 524
1 HUMAN IMMUNOGLOBULIN G 154
2 RANIBIZUMAB 56
3 SODIUM CHLORIDE 50
4 FARICIMAB 43
5 PREDNISOLONE 33
6 PREDNISOLONE ORAL 33
7 PREDNISOLONE ORAL SOLUTION 33
8 POVIDONE-IODINE 32
9 SODIUM CHLORIDE TABLET 28
See all common drugs associated with SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT

SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antiseptic [EPC] 32 0.0073
1 Benzodiazepine Antagonist [EPC] 5 0.0056
2 Vascular Endothelial Growth Factor Inhibitor [EPC] 551 0.0030
3 Human Blood Coagulation Factor [EPC] 2 0.0024
4 Interleukin-6 Antagonist [EPC] 1 0.0015
5 Lipid Emulsion [EPC] 4 0.0015
6 Opioid Antagonist [EPC] 1 0.0010
7 Human Immunoglobulin G [EPC] 15 0.0007
8 Lipopeptide Antibacterial [EPC] 6 0.0006
9 Vitamin K [EPC] 5 0.0006
See all drug classes enriched for association with SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT